This application claims the priority benefit of U.S. Provisional Patent Application Ser. No. 60/582,867 filed on Jun. 25, 2004, which is hereby incorporated herein by reference in its entirety for all purposes.
The present invention relates generally to medical devices and, more particularly, to a lancing device for penetrating the skin of a human or animal subject for sampling of blood and/or other body fluids.
Lancing devices are used to penetrate the skin of a subject and obtain a sample of blood or other body fluid, as in the testing of blood sugar levels by diabetics. Typically, a lancet having a sharp point is translationally mounted within a housing portion of a lancing device. The lancet is driven by a spring or other biasing means to cause the sharp point to extend a small distance through an opening in the housing and into the subject's skin, creating a wound from which the sample of body fluid is collected. The housing optionally includes a pressure surface for “pumping” the wound to enhance sample size, and may also incorporate a capillary tube or other sample collection media. The endcap of the housing or a portion of the housing adjacent the lancet opening may include an open window or a transparent section for viewing the sample collection site, and may also include one or more sample size indicators for comparing the size of a sample to a desired sample size. Example lancing devices are shown in U.S. Pat. Nos. 5,356,420; 5,397,334; and 5,439,473, all of which are hereby incorporated herein by reference.
Lancing devices typically are intended either for a single use or for multiple uses. Single-use lancing devices generally are disposed of after one use. For example, in a hospital or clinic, it is desirable to provide a single-use lancing device that can be used on a patient and then disposed of to eliminate any risk of infection to subsequent patients or caregivers from exposure to residual body fluids remaining on the lancing device. Accordingly, single-use lancing devices oftentimes include a disabling mechanism to prevent accidental or intentional re-use of the device. Various forms of disabling mechanisms are available, and are well known in the art. For example, the disabling mechanism may comprise a return spring for retracting the sharp point of the lancet back into the housing after a single use, break-away elements or a frangible link in the cocking or triggering mechanism to prevent re-arming or re-firing the device after a single use, a locking element, and/or a shield for blocking travel of the lancet.
Because single-use lancing devices normally are disposed of after one use, they generally are relatively simple in construction so that they can be economically manufactured in large quantities. However, most known single-use lancing devices are too costly and/or are not true safety lancets. For example, many single-use lancing devices include a housing, a lancet having a body and a tip, a drive spring for propelling the lancet, an actuator for firing the drive spring, and a retraction spring and disabling mechanism to prevent reuse of the lancing device. With this number of parts, the cost of the lancing device is higher than most users desire. And some other single-use lancing devices eliminate the retraction spring and disabling mechanism to reduce cost. But then these lancing devices permit reuse, so they are not true safety lancets.
Accordingly, a need exists for lancing devices that are simple in construction and therefore low in cost. In addition, it would be desirable for such lancing devices to include disabling means so that they cannot be reused. It is to the provision of lancing devices meeting these and other needs that the present invention is primarily directed.
Briefly described, the present invention provides a lancing device having a housing, an activation/retraction control assembly, and a lancet. The lancet has a body, a puncturing tip that extends from the body, and a removable sterility cap the covers the tip. The housing has a lancing opening through which the puncturing tip extends in its fully extended position to puncture the skin. And the activation/retraction control assembly includes structures that operate to drive the lancet from a ready position to the fully extended position, and then to retract the lancet so that the tip is back inside the housing.
Preferably, these three components include all of the structural features of the lancing device, so no other parts are needed. In addition, these three components preferably are made of molded plastic and can be easily assembled together. In this way, the lancing device provides a reliable safety lancet that is very inexpensive to produce.
The control assembly and the housing have cooperating engagement structures that hold the control assembly in place relative to the housing in the ready position. When a predetermined launch force is applied to a pressing member of the control assembly, the cooperating engagement structures disengage, and the control assembly and the lancet are thus launched in the lancing stroke. The predetermined force is large enough to overcome the resistive force of the cooperating engagement structures and launch the lancet with enough force to ensure that it travels all the way to the fully extended position. In this way, the lancet is driven to its puncturing position without the use of a drive spring.
In addition, the control assembly and the lancet have cooperating releasable engagement structures that hold the lancet to the control assembly when the lancet is driven from the ready position to the fully extended position. But when the lancet is stopped at its fully extended puncturing position, the cooperating releasable engagement structures disengage as the launch force drives the control assembly free of the lancet. The freed control assembly continues moving forward until it is stopped, and then its angled retraction structures engage and retract the lancet so that its puncturing tip is safely within the housing.
In a first example embodiment, the cooperating engagement structures are provided by detents on the housing inner walls and on control arms extending from the pressing member of the control assembly. In addition, the lancing device may include a second detent or other engagement structure for holding the control assembly in its fully depressed position, to prevent retracting the control assembly and reusing the lancing device.
The cooperating releasable engagement structures are provided by notched sections of control fingers that extend from the pressing member of the control assembly, and ramped protrusions on the body of the lancet. The notched sections receive and hold the ramped protrusions so that the lancet and the control assembly move together when the control assembly it depressed and launched. But when the lancet is stopped in the fully extended position with the control member being free to continue moving forward, the notched sections are driven downward along the ramped protrusion. This forces the notched sections outward as they move downward, in the process storing a charge in the control fingers, until they are past the outermost part of the ramped protrusions. Now the notched sections are disengaged from the ramped protrusions, which disables the lancing device from reuse. When the control assembly reaches its fully depressed position, it is held in there by the second engagement structure. The angled retraction structures are provided by angled sections of the control fingers, and they are now engaged with the ramped protrusions. The angled sections of the charged control fingers then bias the lancet back up until the tip is back inside the housing.
In a second example embodiment, the releasable engagement structures are switched between the control assembly and the lancet. In other words, the notched sections are defined by the lancet body and the ramped protrusions are defined by the control fingers, instead of vice versa. In addition, the angled retraction sections are defined by the lancet body instead of the control fingers. Nevertheless, in this configuration the lancing device operates in substantially the same way as the first embodiment does.
In a third example embodiment, the ramped protrusions together have the shape of an inverted heart or letter “V”. And in a fourth example embodiment, the ramped protrusions together are delta-shaped. In these configurations, each of the ramped protrusions are generally wedge-shaped and have lock surfaces that prevent the lancet from being pulled from engagement with the control assembly when the user pulls the sterility cap off for use.
Accordingly, the lancing device may be provided as three (or another small number) pieces of plastic that are easily assembled together. And the lancing device does not need a drive spring, as conventional lancing devices do. In this way, the lancing device is very inexpensive to manufacture as a single-use disposable unit. In addition, the lancing device retracts the lancet after use and is disabled from reuse, so it is a true safety lancet.
These and other aspects, features and advantages of the invention will be understood with reference to the drawing figures and detailed description herein, and will be realized by means of the various elements and combinations particularly pointed out in the appended claims. It is to be understood that both the foregoing general description and the following brief description of the drawings and detailed description of the invention are exemplary and explanatory of preferred embodiments of the invention, and are not restrictive of the invention, as claimed.
The present invention may be understood more readily by reference to the following detailed description of example embodiments taken in connection with the accompanying drawing figures, which form a part of this disclosure. It is to be understood that this invention is not limited to the specific devices, methods, conditions or parameters described and/or shown herein, and that the terminology used herein is for the purpose of describing particular embodiments by way of example only and is not intended to be limiting of the claimed invention. Also, as used in the specification including the appended claims, the singular forms “a”, “an”, and “the” include the plural, and reference to a particular numerical value includes at least that particular value, unless the context clearly dictates otherwise. Ranges may be expressed herein as from “about” or “approximately” one particular value and/or to “about” or “approximately” another particular value. When such a range is expressed, another embodiment includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about”, it will be understood that the particular value forms another embodiment.
Referring now to the drawings,
The lancing device 10 includes a housing 12, a lancet 14, and an activation/retraction control assembly 16. Preferably, each of these components is a single piece, so that the entire lancing device 10 consists of only three parts, thereby keeping its cost low. Alternatively, the control assembly 16 may be manufactured integrally as part of the housing 12 or the lancet 14, with thin-walled zones for breaking into separate parts during use. Of course, the lancing device 10 may be configured with additional components, or with these components made of multiple pieces (e.g., with a plastic lancet body and a metal lancet needle), if desired.
In the depicted embodiment, the housing 12 is a single piece molded of plastic having four sidewalls and a bottom/distal wall forming an interior space with an open top/proximal end. In addition, the housing 12 has two flanges adjacent the open top end that extend outwardly for positioning the user's fingers during use. The lancet 14 includes a body 18 and a sharp puncturing end 20. The lancet body 18 is movable along a guide structure 22, for example, two ridges on each of the opposing front and back sidewalls of the housing 12 that define a channel that receives the lancet body (see
Generally described, the control assembly 16 and the housing 12 have at least one first set of cooperating engagement structures 34 and 35 for holding the control assembly in a ready position. Preferably, the control assembly 16 and/or the housing 12 also has at least one second cooperating engagement structure 36 for holding the control assembly in a finished position after the lancing stroke. Preferably, the second cooperating engagement structure 36 engages one of the first cooperating engagement structures 35 to hold the control assembly in the finished position, but a separate set of second cooperating engagement structures may be provided, if so desired. In addition, the control assembly 16 and the lancet 14 have at least one set of cooperating releasable engagement structures 42 and 44 for releasably holding the lancet to the control assembly during the lancing stroke. And the control assembly 16 has at least one angled retraction structure 40 for retracting the lancet after the lancing stroke.
The control assembly 16 is configured for launching the lancet 14, but only after a predetermined amount of force has been applied by the user to overcome the resistive force of the first cooperating engagement structures 34 and 35. The control assembly 16 is configured so that the required launch force is large enough that, once launched, the control assembly drives the lancet 14 into the skin and all the way to its fully extended position. In addition, the control assembly 16 is configured so that the required launch force is also large enough that, once the lancet 14 is stopped in its fully extended position, the releasable engagement structures 42 and 44 disengage and the control assembly continues to travel to its finished position. Preferably, when the control assembly 16 is stopped in its finished position, the second cooperating engagement structure 36 is engaged by one of the first cooperating engagement structures 35 to hold the control assembly from being pulled out of the housing 12 to reuse the lancing device 10. Now the control assembly 16 and the lancet 14 are in relative positions so that the angled retraction structure 40 biases the lancet 14 back into the housing 12 so that the lancing device 10 cannot be reused.
In the depicted embodiment, the activation/retraction control assembly 16 is a single piece molded of plastic having a pressing member 28 with two (or another number of) launch control arms 30 and two (or another number of) resilient lancet control fingers 32 extending downward into the interior space of the housing 12. The pressing member 28 provides a surface for the user to depress with a finger or palm of the hand, and preferably is sized and shaped to cover the open top of the housing 12. The launch control arms 30 and the housing 12 include the first set of cooperating engagement structures 34 and 35 (see
In a typical commercial embodiment, the cooperating engagement structures 34, 35, and 36 are detents defined by the launch control arms 30 and the housing 12, respectively. For example, the engagement structures 34 may be female detents in the launch control arms 30 and the engagement structures 35 may be male detents on the housing 12, or vice versa. And the engagement structures 36 may be female detents in the launch control arms 30, similar to and spaced apart from the female detent engagement structures 34. Alternatively, the cooperating engagement structures 34, 35, and 36 may be provided by other conventional structures and/or in other quantities selected for carrying out the purposes described herein. In one such alternative embodiment, the cooperating engagement structures 34 and 35 are provided by thin-walled zones that fail under the launch force when the pressing member 28 is depressed. And, of course, the engagement structures 34 and 36 may be defined by the housing 12 and the engagement structures 35 defined by the launch control arms 30, if desired.
In addition, the depicted embodiment has the cooperating releasable engagement structures 42 and 44 provided by notched sections of the lancet control fingers 32 and ramped protrusions on the lancet body 18, respectively. The notched sections 42 and the protrusions 44 are configured so that they are held together and travel together until the lancet 14 is stopped in the fully extended position, at which time the notches slide down the ramped protrusions, which pushes apart the resilient lancet control fingers 32, until the notches are past the protrusions, leaving the control assembly 16 free to continue traveling. Furthermore, the angled retraction structures 40 are provided by angled sections of the lancet control fingers 32. The angled sections 40, which are now resiliently deflected outwardly, push inwardly (to their neutral position) against the protrusions 44, which biases the lancet 14 upward and retracts it into the housing 12 after puncturing the skin. Alternatively, the cooperating releasable engagement structures 42 and 44 and the angled retraction structures 40 may be provided by other conventional structures and/or in other quantities selected for carrying out the purposes described herein. In one such alternative embodiment, the cooperating releasable engagement structures 42 and 44 are provided by a plurality of detents configured to withstand the launch force when the lancet 14 enters the skin but to give and disengage when the lancet is stopped in the fully extended position. In another alternative embodiment, the cooperating releasable engagement structures 42 and 44 include thin-walled zones that fail under the launch force when the lancet 14 is stopped.
The operation of the lancing device 10 will now be described.
Referring to
In this way, the lancet 14 is driven manually by the energy of the user, without a drive spring. This innovative design reduces the number of parts and the size of the lancing device 10, contributing to a lower cost of manufacture.
The predetermined force required to overcome the detents 34 and 35 is selected to be large enough that, after the lancet 14 has been stopped, the residual force is sufficient to overcome the resistive force of the engaged notched sections 42 and protrusions 44. With the lancet 14 stopped in its fully extended position shown in
The control assembly 16 is now held in its stopped position by the restraining engagement of the second detent engagement structures 36 and the first detent engagement structures 35, as shown in
In alternative embodiments, the activation/retraction control assembly 16 may be provided with the releasable engagement structures 42 and 44 and the retraction structure 40 in other configurations for achieving substantially the same result of activating the lancet and then retracting it so that the lancing device is disabled. For example, the notches and ramped protrusions of the control fingers and the lancet body may be switched, and the angled sections may be provided on the lancet body instead of on the control fingers to accomplish the inventive concept of the present invention.
In addition, the sterility cap 326 defines one or more stop surfaces 346 that extend beyond the dimension of the housing's lancing opening 324 to prevent the sterility cap from being inserted through the opening far enough to force the control assembly 316 back to the ready position. For example, the stop surfaces 346 may be defined by two or another number of wedge-shaped protrusions on the sterility cap 326.
In an alternative embodiment, the control assembly and the lancet are manufactured as a single integral piece, without the lancet-control assembly disengagement feature described herein, but with the detents or other cooperating engagement structures. And in another alternative embodiment, the lancing device is provided with a drive spring (without the detents or other cooperating engagement structures), but the control assembly and the lancet are provided with the cooperating releasable engagement structures.
While the invention has been described with reference to preferred and example embodiments, it will be understood by those skilled in the art that a variety of modifications, additions and deletions are within the scope of the invention, as defined by the following claims.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US05/22739 | 6/24/2005 | WO | 12/7/2006 |
Number | Date | Country | |
---|---|---|---|
60582867 | Jun 2004 | US |